|Institutional Source||Beutler Lab|
|Gene Name||Hbs1-like (S. cerevisiae)|
|Essential gene?||Non essential (E-score: 0.000)|
|Stock #||R5069 (G1)|
|Chromosomal Location||21295979-21368898 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to A at 21354647 bp (GRCm38)|
|Amino Acid Change||Serine to Threonine at position 496 (S496T)|
|Ref Sequence||ENSEMBL: ENSMUSP00000020153 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000020153] [ENSMUST00000218714] [ENSMUST00000219915]|
|PDB Structure||Solution structure of HBS1-like domain in hypothetical protein BAB28515 [SOLUTION NMR]|
AA Change: S496T
PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
AA Change: S496T
AA Change: S499T
PolyPhen 2 Score 0.979 (Sensitivity: 0.75; Specificity: 0.96)
|Coding Region Coverage||
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the GTP-binding elongation factor family. It is expressed in multiple tissues with the highest expression in heart and skeletal muscle. The intergenic region of this gene and the MYB gene has been identified to be a quantitative trait locus (QTL) controlling fetal hemoglobin level, and this region influnces erythrocyte, platelet, and monocyte counts as well as erythrocyte volume and hemoglobin content. DNA polymorphisms at this region associate with fetal hemoglobin levels and pain crises in sickle cell disease. A single nucleotide polymorphism in exon 1 of this gene is significantly associated with severity in beta-thalassemia/Hemoglobin E. Multiple alternatively spliced transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, May 2009]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Hbs1l||
(F):5'- CGGAATGAGCCTTCAGTTTCTG -3'
(R):5'- GGAGTTGTAACTAGACTACTGAAGC -3'
(F):5'- GGAATGAGCCTTCAGTTTCTGTAATC -3'
(R):5'- CAGAAATCTGCTGTCTCAAGGC -3'